|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Pulmonary Disease (Dr. Koksal), Internal Medicine (Dr. Buyukbese), Cardiology (Dr. Guven), and Internal Medicine (Dr. Cetinkaya), Kahramanmaras Sutcu Imam University School of Medicine, Kahramanmaras, Turkey; and Department of Pulmonary Disease (Dr. Hasanoglu), Turgut Ozal Medical Center, Inonu University, Malatya, Turkey.
Correspondence to: Nurhan Koksal, MD, FCCP, Kahramanmaras Sutcu Imam University School of Medicine, Department of Pulmonary Disease, Kahramanmaras, Turkey 46050; e-mail: koksalnurhan{at}hotmail.com
| Abstract |
|---|
|
|
|---|
Key Words: mouth-to-mouth breathing organophosphate poisoning secondary contamination
| Introduction |
|---|
|
|
|---|
OP poisoning occurs as a result of accidental exposure or deliberate ingestion.3 Diagnosis is based on the history of exposure or ingestion, the clinical picture of cholinergic overactivity, and measurement of the reduced levels of pseudocholinesterase in the blood serum.1 Early diagnosis and appropriate treatment often is life-saving.4 Additionally, supportive treatment of patients with OP poisoning consists of IV atropine and oximes.4 5 We report here on three patients who were intoxicated with OPs.
| Case Reports |
|---|
|
|
|---|
Case 2
On the same occasion, a 34-year-old man, one of the friends of the young woman reported in case 1, was found in a state of confusion. He was adynamic, and the findings of his physical examination were remarkable for a BP of 100/60 mm Hg, a pulse rate of 110 beats/min, and myotic pupils with a cool and sweaty face and extremities. Diffuse wheezing was heard in the lungs.
Case 3
The second friend of the suicide victim reported on in case 1 was a 29-year-old woman. She informed us that she and the patient described in case 2 had performed mouth-to-mouth breathing on the way to hospital and that hypersalivation and fasciculation had been observed. On examination, her BP was 90/60 mm Hg, her pulse was 120 beats/min, and her skin was cool. The levels of other physiologic systems were within normal limits.
Saline solution infusion was started for the patients in cases 2 and 3, and oxygen was administered. A Foley urine catheter was inserted to follow the urine output effectively. All clothes were taken off the patients, and they were washed with soap thoroughly. Two milligrams of atropine was given IV in 5-min intervals. The second line was reserved for the administration of pralidoxime at a dose of 50 mg/kg. The treatment of both patients was carried out in the ICU. Three days later all symptoms and physical signs had disappeared, and they were discharged from the hospital.
| Discussion |
|---|
|
|
|---|
Health-care workers may be affected via contaminated equipment, clothes, or even by the patients themselves. Emergency staff should pay extra attention to hazardous chemicals, volatile compounds, or particulate matter.6
Geller and coworkers7 reported that three health-care workers were affected in an ED after they had cared for an intoxicated patient who was known to have been exposed to OP over a period of 1 h. In that case, the investigators applied gastric lavage, intubation, and decontamination of the skin, provided respiratory support, and transferred the patient later to the ICU. All three health-care workers were affected, but one was so seriously affected that she had to be kept in the hospital for 9 days. The first day she received breathing support with a ventilator, and for the other 8 days of her hospital stay she was treated with atropine. The National Institute for Occupational Safety and Health identified 46 health-care workers between 1987 and 1998 who had experienced acute pesticide-related illnesses after providing care to pesticide-contaminated patients.6
Depending on the extent of the contamination, health-care workers caring for chemically contaminated patients should use full face masks to prevent dermal and inhalational exposure.7 8 ED and ICU sections of hospitals should review their precautions for health-care workers because of the cases described here.
| Footnotes |
|---|
Received for publication December 10, 2001. Accepted for publication March 27, 2002.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Part 2: Adult Basic Life Support Circulation, November 29, 2005; 112(22_suppl): III-5 - III-16. [Full Text] [PDF] |
||||
![]() |
S. W. Wiener and R. S. Hoffman Nerve Agents: A Comprehensive Review J Intensive Care Med, January 1, 2004; 19(1): 22 - 37. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |